College of Animal Science and Technology, Zhejiang A & F University, Lin'an, China.
College of Animal Science, Zhejiang University, Hangzhou, China.
Lett Appl Microbiol. 2020 Feb;70(2):118-127. doi: 10.1111/lam.13255. Epub 2019 Dec 18.
The aim of this study was to determine whether Lactobacillus rhamnosus GG (LGG) components (surface layer protein, SLP; genomic DNA, gDNA; unmethylated cytosine-phosphate-guanine-containing oligodeoxynucleotide, CpG-ODN), alone or in combination, could affect immunomodulation, and evaluate the signalling mechanism in mouse macrophage RAW264.7 cells challenged with lipopolysaccharide (LPS). LGG components were used to treat cells before LPS stimulation. Cytokine and Toll-like receptor (TLR) expression were assessed using real-time quantitative PCR (RT-qPCR). Mitogen-activated protein kinase (MAPK), extracellular regulated protein kinase (ERK) and nuclear factor-kappa B (NF-κB) signalling pathways were evaluated using immunoblots and immunofluorescence. SLP or SLP + gDNA pre-treatment significantly reduced the LPS-induced mRNA expression of tumour necrosis factor alpha (TNF-α). Pre-treatment with LGG single components (SLP, gDNA or CpG) or their combinations (SLP + gDNA or SLP + CpG) significantly decreased the LPS-induced interleukin-6 (IL-6) mRNA level (P < 0·05). Pre-treatment with SLP or gDNA, alone or in combination, significantly suppressed LPS-induced TLR2 and TLR4 mRNA levels (P < 0·05). SLP pre-treatment also significantly decreased the LPS-induced expression of TLR9 (P < 0·05). Pre-treatment with LGG single components or combinations significantly suppressed the LPS-induced phosphorylation levels of ERK (P > 0·05). In conclusion, pre-incubation with LGG components, singly or in combination, generally inhibited the activation of TLR, MAPK and NF-κB signalling pathways in LPS-stimulated cells, leading to attenuated inflammatory cytokine TNF-α and IL-6 production. These results indicate that nonviable probiotic LGG components exert an anti-inflammation effect on epithelial cells. SIGNIFICANCE AND IMPACT OF THE STUDY: Lactobacillus rhamnosus GG (LGG) is widely used as probiotics. However, its main components are not well known for affecting immunomodulation. This study investigated the effects of pre-treatments with different components such as surface layer protein, genomic DNA and unmethylated cytosine-phosphate-guanine-containing oligodeoxynucleotides, alone or in combination on immunomodulation, and evaluated the signalling mechanism in mouse macrophage RAW264.7 cells challenged with lipopolysaccharide. Pre-incubation with components alone or in combination generally inhibited the activation of Toll-like receptor, mitogen-activated protein kinases, extracellular regulated protein kinases and nuclear factor-kappa B signalling pathways in lipopolysaccharide-stimulated cells, which generally leads to attenuated inflammatory cytokine interleukin-6 and tumour necrosis factor alpha production. These results indicate that nonviable probiotic LGG components exert an anti-inflammation effect on epithelial cells.
本研究旨在确定鼠李糖乳杆菌 GG(LGG)的成分(表面层蛋白、基因组 DNA、未甲基化的胞嘧啶-磷酸-鸟嘌呤寡脱氧核苷酸、CpG-ODN)单独或组合使用是否能够影响免疫调节,并评估其在脂多糖(LPS)刺激的小鼠巨噬细胞 RAW264.7 细胞中的信号转导机制。LGG 成分在 LPS 刺激前用于处理细胞。使用实时定量 PCR(RT-qPCR)评估细胞因子和 Toll 样受体(TLR)的表达。使用免疫印迹和免疫荧光评估丝裂原活化蛋白激酶(MAPK)、细胞外调节蛋白激酶(ERK)和核因子-κB(NF-κB)信号通路。SLP 或 SLP+gDNA 预处理可显著降低 LPS 诱导的肿瘤坏死因子-α(TNF-α)mRNA 表达。单独使用 LGG 单一成分(SLP、gDNA 或 CpG)或其组合(SLP+gDNA 或 SLP+CpG)预处理可显著降低 LPS 诱导的白细胞介素-6(IL-6)mRNA 水平(P<0.05)。单独使用 SLP 或 gDNA 预处理,或联合使用,均可显著抑制 LPS 诱导的 TLR2 和 TLR4 mRNA 水平(P<0.05)。SLP 预处理还显著降低了 LPS 诱导的 TLR9 表达(P<0.05)。单独使用 LGG 单一成分或组合预处理可显著抑制 LPS 诱导的 ERK 磷酸化水平(P>0.05)。总之,LGG 成分单独或组合预处理通常抑制了 LPS 刺激细胞中 TLR、MAPK 和 NF-κB 信号通路的激活,导致炎症细胞因子 TNF-α和 IL-6 的产生减少。这些结果表明,死菌益生菌 LGG 成分对上皮细胞具有抗炎作用。
研究的意义和影响:鼠李糖乳杆菌 GG(LGG)被广泛用作益生菌。然而,其主要成分对于影响免疫调节的作用尚不清楚。本研究调查了不同成分(如表面层蛋白、基因组 DNA 和未甲基化的胞嘧啶-磷酸-鸟嘌呤寡脱氧核苷酸)的单独或组合预处理对免疫调节的影响,并评估了其在脂多糖刺激的小鼠巨噬细胞 RAW264.7 细胞中的信号转导机制。单独或联合预处理成分通常抑制了 LPS 刺激细胞中 Toll 样受体、丝裂原活化蛋白激酶、细胞外调节蛋白激酶和核因子-κB 信号通路的激活,这通常导致炎症细胞因子白细胞介素-6 和肿瘤坏死因子-α的产生减少。这些结果表明,死菌益生菌 LGG 成分对上皮细胞具有抗炎作用。
Korean J Gastroenterol. 2012-8
Food Sci Nutr. 2025-3-16
Probiotics Antimicrob Proteins. 2025-2-18
Transl Pediatr. 2024-8-31
Rev Assoc Med Bras (1992). 2024
Microorganisms. 2024-4-14
Food Chem X. 2024-3-16
Front Microbiol. 2024-3-4